Cart
sales@molnova.com
IRAK inhibitor 3
CAS No. 1012343-93-9
IRAK inhibitor 3( —— )
Catalog No. M26259 CAS No. 1012343-93-9
IRAK inhibitor 3 is an interleukin-1 (IL-1) receptor-associated kinase (IRAK) modulator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 250 | Get Quote |
|
| 2MG | 136 | Get Quote |
|
| 5MG | 227 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIRAK inhibitor 3
-
NoteResearch use only, not for human use.
-
Brief DescriptionIRAK inhibitor 3 is an interleukin-1 (IL-1) receptor-associated kinase (IRAK) modulator.
-
DescriptionIRAK inhibitor 3 is an interleukin-1 (IL-1) receptor-associated kinase (IRAK) modulator.(In Vitro):IRAK inhibitor 3 can be used for treating an inflammatory condition, cell proliferative disorder, immune disorder.is an IRAK modulator.
-
In VitroIRAK inhibitor 3 is an IRAK modulator, which can be used for treating an inflammatory condition, cell proliferative disorder, immune disorder.
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetIRAK
-
RecptorSHP-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1012343-93-9
-
Formula Weight439.49
-
Molecular FormulaC21H21N5O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 13 mg/mL (29.58 mM)
-
SMILESCOc1ccc(cc1OC)-c1cnc2ccc(NCc3ccc(cc3)S(N)(=O)=O)nn12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nichols RJ, et al. RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers. Nat Cell Biol. 2018 Sep;20(9):1064-1073.
molnova catalog
related products
-
GLPG2534
GLPG2534 is an orally active, selective and potent IRAK4 inhibitor with anti-inflammatory activity. GLPG2534 inhibits human and mouse IRAK4 and could be used to study psoriasis and atopic dermatitis.
-
PF-05387252
A potent, selective IRAK4 inhibitor with IC50 of 1.3 nM, 200-fold selectivity over IRAK1 (IC50=290 nM).
-
Zabedosertib
Zabedosertib (BAY 1834845) is an inhibitor of IRAK4 with immunomodulatory potential. Zabedosertib protects against acute respiratory distress syndrome, a new study suggests.
